Back
Immuneering Vs. Biomarin Pharmaceutical Industry Stock Comparison
Buy
84
IMRX
Immuneering
Last Price:
3.19
Seasonality Move:
-30.59%
Sell
35
BMRN
Biomarin Pharmaceutical
Last Price:
70.70
Seasonality Move:
5.7%
Buy
84
Immuneering (IMRX)
is a Buy
Is Immuneering a Buy, Sell or Hold?
- The current Immuneering [IMRX] share price is $3.19. The Score for IMRX is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
- IMRX is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
35
Biomarin Pharmaceutical (BMRN)
is a Sell
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $70.69. The Score for BMRN is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- BMRN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IMRX Stock Price Chart
What is Immuneering's stock price today?
-
The Immuneering share price today is $3.19
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IMRX is experiencing slight buying pressure.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $70.69
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight selling pressure.
IMRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.41 | Buy |
| Relative Strength Index (14 RSI): | 77.25 | Buy |
| Chaikin Money Flow: | 11044620 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.85 - 2.15) | Buy |
| Bollinger Bands (100): | (1.03 - 1.75) | Buy |
BMRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.4 | Sell |
| Relative Strength Index (14 RSI): | 22.78 | Sell |
| Chaikin Money Flow: | -1009919 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (77.4 - 92.98) | Sell |
| Bollinger Bands (100): | (78.06 - 88.38) | Sell |
IMRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.29 | Buy |
| 20-day SMA: | 1.61 | Buy |
| 50-day SMA: | 1.34 | Buy |
| 200-day SMA: | 3.28 | Sell |
| 8-day EMA: | 2.36 | Buy |
| 20-day EMA: | 1.84 | Buy |
| 50-day EMA: | 1.54 | Buy |
| 200-day EMA: | 3.04 | Buy |
BMRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 75.96 | Sell |
| 20-day SMA: | 83.55 | Sell |
| 50-day SMA: | 85.45 | Sell |
| 200-day SMA: | 86.8 | Sell |
| 8-day EMA: | 75.07 | Sell |
| 20-day EMA: | 80.72 | Sell |
| 50-day EMA: | 83.8 | Sell |
| 200-day EMA: | 85.86 | Sell |
Immuneering Earnings Growth & IMRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.17 per share, an increase this year of $0.01 per share, and an increase next year of $0.20 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.29 per share, an increase this year of $1.19 per share, and an increase next year of $1.04 per share.
Immuneering Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biomarin Pharmaceutical Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||